Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000244 · ClinicalTrials.gov registry record · Phase 2
Effects of Dynorphin 1-13 on Heroin Addiction - 1
A Phase 2 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00000244 is a Phase 2 study that has completed, run by University of Minnesota.
The verdict
NCT00000244, a Phase 2 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to evaluate the effects of IV dynorphin in humans during acute heroin abstinence, in order to determine that dynorphin suppresses acute opiate withdrawal, reduces opiate craving, and is safe at doses required to produce the above effects.
Interventions
- DRUG Dynorphin 1 - 13
Trial Details
| Field | Value |
|---|---|
| Start Date | 1994-08 |
| Est. Completion | 1997-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000244
The ClinicalTrials.gov registry entry for NCT00000244 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dynorphin 1 - 13 is the first listed.
NCT00000244 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000244 about?
NCT00000244 is a clinical study titled "Effects of Dynorphin 1-13 on Heroin Addiction - 1". The purpose of this study is to evaluate the effects of IV dynorphin in humans during acute heroin abstinence, in order to determine that dynorphin suppresses acute opiate withdrawal, reduces opiate craving, and is safe at doses required to produce the above effects.
What is the current status of trial NCT00000244?
This trial is currently completed. It is a Phase 2 study. The study started on 1994-08. Estimated completion is 1997-03.
What interventions are being tested in trial NCT00000244?
The interventions under investigation include: Dynorphin 1 - 13 (DRUG).
Who is sponsoring clinical trial NCT00000244?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.